Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10,325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pembrolizumab for the treatment of esophageal cancer.
Yamamoto S, Kato K. Yamamoto S, et al. Expert Opin Biol Ther. 2020 Oct;20(10):1143-1150. doi: 10.1080/14712598.2020.1792881. Epub 2020 Jul 14. Expert Opin Biol Ther. 2020. PMID: 32620063 Review.
Nivolumab for the treatment of esophageal cancer.
Mikuni H, Yamamoto S, Kato K. Mikuni H, et al. Among authors: yamamoto s. Expert Opin Biol Ther. 2021 Jun;21(6):697-703. doi: 10.1080/14712598.2021.1904887. Epub 2021 Mar 29. Expert Opin Biol Ther. 2021. PMID: 33736560
Emerging data on nivolumab for esophageal squamous cell carcinoma.
Hirose T, Yamamoto S, Kato K. Hirose T, et al. Among authors: yamamoto s. Expert Rev Gastroenterol Hepatol. 2021 Aug;15(8):845-854. doi: 10.1080/17474124.2021.1948836. Epub 2021 Jul 12. Expert Rev Gastroenterol Hepatol. 2021. PMID: 34251958 Review.
Pembrolizumab for the treatment of advanced esophageal cancer.
Harada K, Yamamoto S, Kato K. Harada K, et al. Among authors: yamamoto s. Future Oncol. 2022 Jun;18(18):2311-2319. doi: 10.2217/fon-2022-0108. Epub 2022 Apr 14. Future Oncol. 2022. PMID: 35418242 Free article. Review.
10,325 results
You have reached the last available page of results. Please see the User Guide for more information.